Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of cancer therapy-related diarrhea
OnTarget results in breast cancer patients have been submitted to a relevant oncology conference
Read MoreOnce approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada
Read MoreThe Health and Fitness Summit is hosted by MEFITPRO, the leading distributor of best-in-class brands in the Gulf region
Gulf countries (the "GCC") are growing quickly and fitness adoption is outpacing GDP growth
MEFITPRO distributes CLMBR exclusively in the region and received its six-figure initial order in the third quarter
Jaguar's commercial focus on cancer supportive care aims to use the best tools and techniques that assess the quality of life of cancer patients and survivors and deliver solutions to address these unmet needs - Commonly used tools and techniques fail to measure what patients are most concerned about
Jaguar family company Napo Pharmaceuticals sponsored the "More Than a Diagnosis: A Quality of Life Survey for Individuals with a Diagnosis or History of Cancer"
Read More
PrimaFit, based in Jakarta, is the leading distributor of best-in-class brands in Indonesia and will represent CLMBR exclusively
Indonesia is the largest economy in the region and is a G20 country with high GDP growth
PrimaFit received its initial order in July and placed a larger second order in September that combined is almost six-figures
This press release replaces the release issued today at 9:15am EDT.
Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy.
Revealia™: A Breakthrough in Cancer Detection through Advanced AI and Machine Learning
Read MoreOral mucositis, also called "chemo mouth," has emerged as the most significant adverse event in oncology according to a National Comprehensive Cancer Network task force
Up to 40% of all patients treated with chemotherapy develop oral mucositis, and this percentage rises to approximately 90% for patients with head and neck cancers treated with chemotherapy and radiotherapy
Read MoreOrders from Distributors in Germany, Switzerland and Austria will be fulfilled as soon as possible
Germany and the United Kingdom are two of the largest fitness markets globally
European Union compliance standards are some of the most stringent
Third quarter revenue will be significantly higher than previous quarters
